Reuters logo
BRIEF-Savara reports completion of enrollment
2017年10月18日 / 下午1点05分 / 1 个月前

BRIEF-Savara reports completion of enrollment

Oct 18 (Reuters) - Savara Inc:

* Savara reports completion of enrollment in phase 2 clinical trial of aironite for the treatment of hfpef

* Savara Inc - ‍expects that top-line results from indie-hfpef study will be available in first half of 2018​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below